×
About 1,268 results

ALLMedicine™ Hereditary Hemorrhagic Telangiectasia Center

Research & Reviews  470 results

Injection of cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
https://doi.org/10.1002/alr.23017
International Forum of Allergy & Rhinology; Anciaux M, Lebreton JP et. al.

May 7th, 2022 - Injection of cyanoacrylate glue for hereditary hemorrhagic telangiectasia.|2022|Anciaux M,Lebreton JP,Tonnerre D,Leclerc J,Dufour X,|

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.1053/j.gastro.2022.02.021
Gastroenterology Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Combined transarterial and transvenous embolization of multi-hole pial arteriovenous fi...
https://doi.org/10.1177/19714009221096829
The Neuroradiology Journal; Yamada H, Akiyama T et. al.

Apr 29th, 2022 - Pial arteriovenous fistula (AVF) is a vascular fistulous disease in which the cerebral pial artery and vein are directly connected without the intervening nidus within a sub-pial space. Multi-hole pial AVFs, wherein multiple feeders flow into one ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.14309/ajg.0000000000001755
The American Journal of Gastroenterology; Boland CR, Idos GE et. al.

Apr 27th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

see more →

Guidelines  4 results

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.1053/j.gastro.2022.02.021
Gastroenterology Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrha...
https://doi.org/10.7326/M20-1443
Annals of Internal Medicine; Faughnan ME, Mager JJ et. al.

Sep 8th, 2020 - Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular malformations (VMs). These result in chronic bleeding, acute hemorrhage, and c...

Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: p...
https://doi.org/10.1016/j.clinre.2020.03.008
Clinics and Research in Hepatology and Gastroenterology; Silvain C, Thévenot T et. al.

Apr 7th, 2020 - Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.|2020|Silv...

see more →

Clinicaltrials.gov  15 results

Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia
https://clinicaltrials.gov/ct2/show/NCT02690246

Mar 22nd, 2022 - Specific aspects include potential consequences from iron deficiency, efficacy and safety of self-packing, effect of female sex hormones, mortality, effects on the immune system.

Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient
https://clinicaltrials.gov/ct2/show/NCT04108052

Oct 19th, 2021 - Hereditary hemorrhagic telangiectasia (HHT) is linked to a dysregulation of angiogenesis leading to the formation of arteriovenous malformations (AVM): cutaneo-mucous telangiectasia and visceral shunts. The diagnosis is clinical and based on Curaç...

Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
https://clinicaltrials.gov/ct2/show/NCT04139018

Aug 24th, 2021 - This study is a double-blinded, placebo-controlled, 8-week randomized clinical trial investigating the efficacy of timolol gel in the management of epistaxis in adults with HHT. The Specific Aims are to determine in adults with HHT-associated epis...

Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy
https://clinicaltrials.gov/ct2/show/NCT01856842

Oct 22nd, 2020 - Introduction Pulmonary arteriovenous malformations (AVMs) can lead to life-threatening complications. These complications can be prevented with pre-symptomatic embolization. The Interlock™ Fibered IDC™ Occlusion System coil (IDC) is a new device w...

Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
https://clinicaltrials.gov/ct2/show/NCT02157987

Oct 5th, 2020 - Epistaxis are present in over 90 % of patients with Rendu - Osler . They involve no significant difference 2 sexes. They often appear in childhood and adolescence and are present in three-quarters of patients at the age of 20 years. These epistaxi...

see more →

News  17 results

Bilateral palmar rash
https://www.mdedge.com/familymedicine/article/253507/dermatology/bilateral-palmar-rash
MDedge Family Medicine;

Apr 6th, 2022 - A biopsy was performed and the pathology report showed ectatic, thin-walled vessels consistent with telangiectasias. There were no other inflammatory, infectious, or malignant changes.

Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines (2020)
https://reference.medscape.com/viewarticle/938166

Sep 30th, 2020 - The Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines were published on September 8, 2020.[1] Management of Epistaxis To reduce HHT-related epistaxis, use moisturizing topical therapies that humidify the nasal mucosa. Con...

Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines (2020)
https://reference.staging.medscape.com/viewarticle/938166

Sep 30th, 2020 - The Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines were published on September 8, 2020.[1] Management of Epistaxis To reduce HHT-related epistaxis, use moisturizing topical therapies that humidify the nasal mucosa. Con...

New Guidelines Expand Management Options for Hereditary Hemorrhagic Telangiectasia
https://www.staging.medscape.com/viewarticle/937096

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

New Guidelines Expand Management Options for Hereditary Hemorrhagic Telangiectasia
https://www.medscape.com/viewarticle/937096

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

see more →

Patient Education  1 results see all →